dilated pores. Other specified disorders of skin and subcutaneous tissue
Conditions
Interventions
Topical anesthetic gel is applied to both sides of face and left for 30minutes. The patient's eyes are covered with a shield during the entire procedure. Patients are assigned to receive treatment wi
which is focused to a spot size of approximately 120 micrometer in diameter ,the pulse duration of 10 milliseconds and pulse energy varies from 5 to 70mJ .Three treatment sessions with 1 month interva
Treatment - Other
Sponsors
Shahid Beheshti University of Medical Science-Skin Research Center
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: females between 18 and 50years of age Exclusion criteria :males ;females younger than 18 year old; pregnancy and lactation; cosmetic procedures affecting the treatment area (e.g.,botulinum toxin ,dermabrasion, chemical peeling, laser surgery, or face-lift)within the last 6months;oral isotretinoin within the last 6months; history of keloid formation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pores improvement. Timepoint: before treatment_before each session_3month after the last session. Method of measurement: improvment percentage_comparing digital photoghraphes by dermatologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects(pain-burning and stinging-erythem-edema-bulla-bleeding-crust formation-hypopigmentation-hyperpigmentation-scar-atrophy). Timepoint: one week after each treatment session. Method of measurement: patient evaluation with questionnaire-dermatologist evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElmira Asadi
Skin Research Center
Outcome results
None listed